Checkmate for hepatitis B viruses in mice liver

Researchers at Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with researchers at the University Medical Center Hamburg-Eppendorf and the University Hospital Heidelberg, have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model. The team showed in its publication, that T-cell therapy can provide a permanent cure. Up to now it has not been possible to fully control the virus.
Their findings have now been published in the Journal of Clinical Investigation.

https://www.helmholtz-muenchen.de/en/press-media/press-releases/all-press-releases/press-release/article/46390/index.html

2 Likes